companydata.dkcompanydata.dk

Merck Life Science A/S: Financial statements 2016

CVR: 20830131

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 20,262,564 and a net result of DKK 6,204,236 compared with DKK 7,405,593 the year before. That is a decrease of 40.9% compared with the year before. Equity in the 2016 report amounted to DKK 41,707,479. The solvency ratio was 59.1%. The company had 17 employees in the financial year.

Gross Profit
DKK 20,262,564
Profit/Loss
DKK 6,204,236
Equity
DKK 41,707,479
Total Assets
DKK 70,589,550
Employees
17

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-20.3M6.2M41.7M17
2015-34.3M7.4M35.5M17
2014-27.5M3.9M28.1M-
2013-26M4.2M24.2M-
201225.8M17.1M4.3M20M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Merck Life Science A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

Merck Life Science A/S: The 2015 annual report is outJun 2, 2016

Merck Life Science A/S has published its annual report for 2015. Gross profit came to DKK 34,274,758, and the net result was DKK 7,405,593.

Franklin Devoe Wicks Jr leaves the board of Merck Life Science A/SJan 1, 2016

As of January 1, 2016, Franklin Devoe Wicks Jr has left the board of directors of Merck Life Science A/S.

About Merck Life Science A/S

Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.

Source: annual report 2025, Danish Business Authority